Identification of functional leptin receptors expressed in ventricular mitochondria

Molecular and Cellular Biochemistry

Volumn 408, Issue 1-2, 2015, Pages 155-162

  Martinez Abundis, Eduardo ^a,c   Rajapurohitam, Venkatesh ^a   Gertler, Arieh ^b   Karmazyn, Morris ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c UNIVERSIDAD JUÁREZ AUTÓNOMA DE TABASCO   (Mexico)

Author keywords

Heart; Mitochondria; Mitochondrial OBR expression; Mitochondrial swelling

Indexed keywords

AMINO ACID; CALCIUM; LEPTIN; LEPTIN RECEPTOR; LEPTIN RECEPTOR OBRB; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; UNCLASSIFIED DRUG; CARRIER PROTEIN; LEPTIN RECEPTOR, HUMAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOGOLD LABELING; MITOCHONDRION; MITOCHONDRION SWELLING; NONHUMAN; RAT; WESTERN BLOTTING; ANIMAL; CARDIAC MUSCLE CELL; CELL CULTURE; CYTOLOGY; HEART VENTRICLE; METABOLISM; NEWBORN;

ANIMALS; ANIMALS, NEWBORN; CALCIUM; CELLS, CULTURED; HEART VENTRICLES; LEPTIN; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCYTES, CARDIAC; RATS; RECEPTORS, LEPTIN;

EID: 84941995727     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-015-2491-2     Document Type: Article

References (14)

1. Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS (2010) Leptin in human physiology and therapeutics. Front Neuroendocrinol 31:377–393
2. Purdham DM, Zou MX, Rajapurohitam V, Karmazyn M (2004) Rat heart is a site of leptin production and action. Am J Physiol Heart Circ Physiol 287:H2877–H2884
3. Rajapurohitam V, Javadov S, Purdham DM, Kirshenbaum LA, Karmazyn M (2006) An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. J Mol Cel. Cardiol 41:265–274
4. Northcott JM, Yeganeh A, Taylor CG, Zahradka P, Wigle JT (2012) Adipokines and the cardiovascular system: mechanisms mediating health and disease. Can J Physiol Pharmacol 90:1029–1059
5. Karmazyn M, Rajapurohitam V (2014) Leptin as a cardiac pro-hypertrophic factor and its potential role in the development of heart failure. Curr Pharm Des 20:646–651
6. Martinez-Abundis E, Rajapurohitam V, Haist JV, Gan XT, Karmazyn M (2012) The obesity-related peptide leptin sensitizes cardiac mitochondria to calcium-induced permeability transition pore opening and apoptosis. PLoS One 7:e41612
7. Abadir PM, Foster DB, Crow M, Cooke CA, Rucker JJ, Jain A, Smith BJ, Burks TN, Cohn RD, Fedarko NS, Carey RM, O’Rourke B, Walston JD (2011) Identification and characterization of a functional mitochondrial angiotensin system. Proc Natl Acad Sci USA 108:14849–14854
8. Chen JQ, Delannoy M, Cooke C, Yager JD (2004) Mitochondrial localization of ERα and ERβ in human MCF7 cells. Am J Physiol Endocrinol Metab 286:E1011–E1022
9. Javadov S, Rajapurohitam V, Kilić A, Hunter JC, Zeidan A, Said Faruq N, Escobales N, Karmazyn M (2011) Expression of mitochondrial fusion-fission proteins during post-infarction remodeling: the effect of NHE-1 inhibition. Basic Res Cardiol 106:99–109
10. Banks AS, Davis SM, Bates SH, Myers MG Jr (2000) Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 275:14563–14572
11. Javadov S, Karmazyn M (2007) Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem 20:1–22
12. Savard M, Barbaz D, Bélanger S, Müller-Ester W, Bkaily G, D’orléans-Juste P, Coté J, Bovenzi V, Gobeil F Jr (2008) Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation. J Cell Physiol 216:234–244
13. Bkaily G, Avedanian L, Al-Khoury J, Ahmarani L, Perreault C, Jacques D (2012) Receptors and ionic transporters in nuclear membranes: new targets for therapeutical pharmacological interventions. Can J Physiol Pharmacol 90:953–965
14. Bkaily G, Al-Khoury J, Jacques D (2014) Nuclear membranes GPCRs: implication in cardiovascular health and diseases. Curr Vasc Pharmacol 12:215–222